Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis

BackgroundInflammation is a risk factor for cardiovascular disease (CVD), and particular inflammatory parameters can be used to predict the incidence of CVD. The aim of this study was to assess the association between fibrinogen (FIB), interleukin-6 (IL-6), C-reactive protein (CRP) and galectin-3 (G...

Full description

Bibliographic Details
Main Authors: Yifei Liu, Suzhen Guan, Haiming Xu, Na Zhang, Min Huang, Zhihong Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1175174/full
_version_ 1797785350428426240
author Yifei Liu
Yifei Liu
Suzhen Guan
Suzhen Guan
Haiming Xu
Haiming Xu
Na Zhang
Na Zhang
Min Huang
Min Huang
Zhihong Liu
Zhihong Liu
author_facet Yifei Liu
Yifei Liu
Suzhen Guan
Suzhen Guan
Haiming Xu
Haiming Xu
Na Zhang
Na Zhang
Min Huang
Min Huang
Zhihong Liu
Zhihong Liu
author_sort Yifei Liu
collection DOAJ
description BackgroundInflammation is a risk factor for cardiovascular disease (CVD), and particular inflammatory parameters can be used to predict the incidence of CVD. The aim of this study was to assess the association between fibrinogen (FIB), interleukin-6 (IL-6), C-reactive protein (CRP) and galectin-3 (Gal-3) and the risk of cardiovascular disease using meta-analysis.MethodsPubMed, Embase, Scopus, and Web of Science databases were searched with the appropriate strategies to identify observational studies relevant to this meta-analysis. A random-effects model was used to combine inflammation factor-associated outcomes and cardiovascular disease outcomes, except in the case of galectin-3, where a fixed-effects model was used because of less heterogeneity. Location, age, type of cardiovascular disease, and sample size factors were used to explore heterogeneity in stratification and metaregression for subgroup analysis. A case-by-case literature exclusion approach was used for sensitivity analysis. The funnel plot and Begg's test were combined to assess publication bias.ResultsThirty-three papers out of 11,456 were screened for inclusion in the analysis. Four inflammation biomarkers were significantly associated with the development of CVD: FIB (OR: 1.21, 95% CI: 1.15–1.27, P < 0.001; HR: 1.04, 95% CI: 1.00–1.07, P < 0.05), IL-6 (HR: 1.16, 95% CI: 1.10–1.22, P < 0.001), CRP (OR: 1.25, 95% CI: 1.15–1.35, P < 0.001; HR: 1.20, 95% CI: 1.14–1.25, P < 0.001) and Gal-3 (HR: 1.09, 95% CI: 1.05–1.14, P < 0.001). Location factors help explain the source of heterogeneity, and there is publication bias in the Gal-3 related literature.ConclusionTaken together, the current research evidence suggests that high levels of fibrinogen, interleukin-6, C-reactive protein and galectin-3 are risk factors for cardiovascular disease and can be used as biomarkers to predict the development of cardiovascular disease to some extent.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO, identifier: CRD42023391844.
first_indexed 2024-03-13T00:52:50Z
format Article
id doaj.art-063139ca23214d1d910b7d12d682617e
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-03-13T00:52:50Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-063139ca23214d1d910b7d12d682617e2023-07-07T08:40:16ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-07-011010.3389/fcvm.2023.11751741175174Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysisYifei Liu0Yifei Liu1Suzhen Guan2Suzhen Guan3Haiming Xu4Haiming Xu5Na Zhang6Na Zhang7Min Huang8Min Huang9Zhihong Liu10Zhihong Liu11School of Public Health, Ningxia Medical University, Yinchuan, ChinaKey Laboratory of Environmental Factors and Chronic Disease Control, Ningxia Medical University, Yinchuan, Ningxia, ChinaSchool of Public Health, Ningxia Medical University, Yinchuan, ChinaKey Laboratory of Environmental Factors and Chronic Disease Control, Ningxia Medical University, Yinchuan, Ningxia, ChinaSchool of Public Health, Ningxia Medical University, Yinchuan, ChinaKey Laboratory of Environmental Factors and Chronic Disease Control, Ningxia Medical University, Yinchuan, Ningxia, ChinaSchool of Public Health, Ningxia Medical University, Yinchuan, ChinaKey Laboratory of Environmental Factors and Chronic Disease Control, Ningxia Medical University, Yinchuan, Ningxia, ChinaSchool of Public Health, Ningxia Medical University, Yinchuan, ChinaKey Laboratory of Environmental Factors and Chronic Disease Control, Ningxia Medical University, Yinchuan, Ningxia, ChinaSchool of Public Health, Ningxia Medical University, Yinchuan, ChinaKey Laboratory of Environmental Factors and Chronic Disease Control, Ningxia Medical University, Yinchuan, Ningxia, ChinaBackgroundInflammation is a risk factor for cardiovascular disease (CVD), and particular inflammatory parameters can be used to predict the incidence of CVD. The aim of this study was to assess the association between fibrinogen (FIB), interleukin-6 (IL-6), C-reactive protein (CRP) and galectin-3 (Gal-3) and the risk of cardiovascular disease using meta-analysis.MethodsPubMed, Embase, Scopus, and Web of Science databases were searched with the appropriate strategies to identify observational studies relevant to this meta-analysis. A random-effects model was used to combine inflammation factor-associated outcomes and cardiovascular disease outcomes, except in the case of galectin-3, where a fixed-effects model was used because of less heterogeneity. Location, age, type of cardiovascular disease, and sample size factors were used to explore heterogeneity in stratification and metaregression for subgroup analysis. A case-by-case literature exclusion approach was used for sensitivity analysis. The funnel plot and Begg's test were combined to assess publication bias.ResultsThirty-three papers out of 11,456 were screened for inclusion in the analysis. Four inflammation biomarkers were significantly associated with the development of CVD: FIB (OR: 1.21, 95% CI: 1.15–1.27, P < 0.001; HR: 1.04, 95% CI: 1.00–1.07, P < 0.05), IL-6 (HR: 1.16, 95% CI: 1.10–1.22, P < 0.001), CRP (OR: 1.25, 95% CI: 1.15–1.35, P < 0.001; HR: 1.20, 95% CI: 1.14–1.25, P < 0.001) and Gal-3 (HR: 1.09, 95% CI: 1.05–1.14, P < 0.001). Location factors help explain the source of heterogeneity, and there is publication bias in the Gal-3 related literature.ConclusionTaken together, the current research evidence suggests that high levels of fibrinogen, interleukin-6, C-reactive protein and galectin-3 are risk factors for cardiovascular disease and can be used as biomarkers to predict the development of cardiovascular disease to some extent.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO, identifier: CRD42023391844.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1175174/fullfibrinogeninterleukin-6C-reactive proteingalectin-3cardiovascular diseasemeta-analysis
spellingShingle Yifei Liu
Yifei Liu
Suzhen Guan
Suzhen Guan
Haiming Xu
Haiming Xu
Na Zhang
Na Zhang
Min Huang
Min Huang
Zhihong Liu
Zhihong Liu
Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis
Frontiers in Cardiovascular Medicine
fibrinogen
interleukin-6
C-reactive protein
galectin-3
cardiovascular disease
meta-analysis
title Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis
title_full Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis
title_fullStr Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis
title_full_unstemmed Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis
title_short Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis
title_sort inflammation biomarkers are associated with the incidence of cardiovascular disease a meta analysis
topic fibrinogen
interleukin-6
C-reactive protein
galectin-3
cardiovascular disease
meta-analysis
url https://www.frontiersin.org/articles/10.3389/fcvm.2023.1175174/full
work_keys_str_mv AT yifeiliu inflammationbiomarkersareassociatedwiththeincidenceofcardiovasculardiseaseametaanalysis
AT yifeiliu inflammationbiomarkersareassociatedwiththeincidenceofcardiovasculardiseaseametaanalysis
AT suzhenguan inflammationbiomarkersareassociatedwiththeincidenceofcardiovasculardiseaseametaanalysis
AT suzhenguan inflammationbiomarkersareassociatedwiththeincidenceofcardiovasculardiseaseametaanalysis
AT haimingxu inflammationbiomarkersareassociatedwiththeincidenceofcardiovasculardiseaseametaanalysis
AT haimingxu inflammationbiomarkersareassociatedwiththeincidenceofcardiovasculardiseaseametaanalysis
AT nazhang inflammationbiomarkersareassociatedwiththeincidenceofcardiovasculardiseaseametaanalysis
AT nazhang inflammationbiomarkersareassociatedwiththeincidenceofcardiovasculardiseaseametaanalysis
AT minhuang inflammationbiomarkersareassociatedwiththeincidenceofcardiovasculardiseaseametaanalysis
AT minhuang inflammationbiomarkersareassociatedwiththeincidenceofcardiovasculardiseaseametaanalysis
AT zhihongliu inflammationbiomarkersareassociatedwiththeincidenceofcardiovasculardiseaseametaanalysis
AT zhihongliu inflammationbiomarkersareassociatedwiththeincidenceofcardiovasculardiseaseametaanalysis